Real-World Data Governance: Tools, Roles and Examples

Real-world data governance is the set of roles, rules and tools that control how health data collected outside clinical trials, such as electronic health records, claims, registries and device data, is accessed, linked, analyzed and released. Good governance lets researchers and life sciences teams turn real-world data into evidence while keeping patients’ privacy, honoring the terms under which the data was collected and leaving a full record of every use.
Why real-world data governance matters now
Real-world data (RWD) now supports decisions that used to rest on trials alone: label expansions, safety monitoring, health technology assessment and the design of new studies. Regulators have published frameworks for using real-world evidence, and payers increasingly ask for it. At the same time, the data comes from organizations that did not collect it for research: hospitals, insurers, pharmacies, disease registries and app makers. Each has its own legal basis, its own consent model and its own appetite for risk.
That makes governance the deciding factor in whether real-world data can be used at all. A data holder will only open access if it can control who uses the data, for what, and what leaves. A regulator will only trust the resulting evidence if the analysis can be traced from raw record to final result. The May 2026 UK Biobank incident, where approved researchers moved data out through a normal workflow, showed that access rules on paper are not enough; the technical setup has to enforce them.
The roles in real-world data governance
Data holder
The hospital, insurer or registry that collected the data. It remains responsible under privacy law, such as HIPAA in the US or GDPR in Europe, and decides whether and how data can be reused.
Data custodian
The team or service that stores and protects the data day to day. Sometimes this is the holder itself, sometimes a national program or a trusted third party acting for it.
Data access committee
A data access committee reviews each request against the legal basis, any consent, ethics approval and the holder’s policy. It approves a specific purpose and dataset for a specific period.
Data user
The researcher, analyst or life sciences team that runs the analysis. Users sign agreements, complete training and accept that their work will be logged and their outputs checked.
Output checker
The person or automated system that reviews results before they leave, to confirm no individual can be identified from them.
The tools that make real-world data governance work
De-identification and pseudonymization
Direct identifiers are removed or replaced with codes before analysis. Techniques such as generalizing dates and locations reduce the risk of re-identification further. These steps lower risk but do not remove it, which is why the controls below still matter.
Privacy-preserving record linkage
Real-world data becomes far more useful when sources are linked, for example joining hospital records to claims or a registry. Linkage using encrypted tokens lets records for the same person be matched without exposing names or identifiers to the analysts.
Common data models
Mapping sources to a shared model, such as OMOP for observational research, makes data comparable and lets one analysis run across many sources. Our guide to data harmonization explains the process.
Secure analysis environments
Instead of sending extracts to users, the custodian gives them a secure workspace with analysis tools next to the data. A Trusted Research Environment is the standard form. It enforces the Five Safes: safe people, safe projects, safe settings, safe data and safe outputs.
Output checking and audit
Every result is checked before release, and every login, query and export is logged. Automated checks make release faster and more consistent than manual review alone.
Extract-based and federated governance compared
The biggest governance decision for real-world data is whether data moves to the user or the analysis moves to the data.
| Dimension | Extract sent to user | Federated analysis |
|---|---|---|
| Where the data goes | A copy leaves the holder | Stays put; data never leaves the source |
| Holder’s control | Ends at hand-over | Continues for every query |
| Linking several holders | All data pooled in one place | Analysis runs at each holder |
| Cross-border use | Needs transfer mechanisms | Only checked results cross borders |
| Audit trail | Holder sees the extract, not its use | Every query and output logged |
| Ending access | Copies may remain | Access is switched off |
Federated analysis is often the only way to use real-world data that law or policy forbids from moving, such as national health records or data held under strict local rules.
It also changes the conversation with data holders. Instead of asking a hospital to hand over records and trust what happens next, a research team asks to run a defined, reviewed analysis that the hospital can watch, approve and stop. Holders that would never agree to an extract will often agree to that, which widens the pool of real-world data available for research.
Common risks in real-world data governance
Real-world data carries risks that trial data usually does not, because it was collected for care or payment rather than research.
Re-identification through linkage
Each dataset may look safe on its own, but linking records from a hospital, a pharmacy and a registry can make a person recognizable. Governance should review the combined dataset, not just each source.
Purpose creep
Data approved for one study gets quietly reused for another. Tie every access grant to a stated purpose, and require a new approval when the question changes.
Unclear provenance
Real-world data passes through several hands before analysis. If nobody records where each field came from and how it was transformed, evidence built on it is hard to defend. Keep a documented chain from source to analysis dataset.
Small-number disclosure
Results for rare diseases or small areas can reveal individuals even when no names appear. Output rules, such as minimum cell counts, guard against that.
Governing AI built on real-world data
Teams increasingly train models on real-world data to predict risk, find patients for trials or spot safety signals. Governance needs three extra checks. First, confirm the legal basis and any consent cover model training, not only statistical analysis. Second, record which data versions trained which model, so results can be reproduced and biases traced. Third, treat trained models as outputs: review them before they leave the secure environment, since a model can sometimes reveal details about the data it learned from.
Examples of real-world data governance
- A national health data program gives approved researchers access to linked hospital and primary care records only inside a secure environment, with every output checked before release.
- A hospital network maps its records to a common data model and joins a research network, where approved studies run locally and only aggregate results are shared.
- A disease registry keeps consent preferences for each participant and filters every dataset so only consented records appear in each approved project.
- A life sciences team studying treatment patterns runs its analysis across several data holders without receiving any patient-level data.
For a wider view of the data types involved, see our real-world data examples.
Building real-world data governance step by step
1. Know your legal basis
For each source, record why you may use it for research: consent, a research exemption under law, or a specific statutory route. That basis sets the limits of every later decision.
2. Set up the access process
Create one route for requests, one committee to review them and standard agreements for users. Publish the criteria so applicants know what to expect.
3. Choose the analysis setting
Decide whether users will receive extracts or work in a secure environment. For sensitive or linked data, a secure environment is now the expected standard.
4. Standardize the data
Map sources to a common model and document every transformation, so evidence can be traced back to the raw records.
5. Check outputs and audit everything
Put output checks in place before the first project starts, and review the audit trail regularly, not only after an incident.
6. Measure and improve
Track the time from request to access, the share of outputs released on first review and the number of data copies outside controlled settings. Publish the figures to data holders and users. Governance that can show it is getting faster and safer earns the trust that opens access to more data.
Frequently asked questions
What is real-world data governance?
It is the framework of roles, rules and tools that controls how health data from routine care, claims, registries and devices is accessed, linked, analyzed and released for research.
What tools help with real-world data governance?
De-identification, privacy-preserving record linkage, common data models, secure analysis environments, output checking and audit logging.
Who is responsible for real-world data governance?
The data holder remains responsible, supported by a custodian, a data access committee, output checkers and the users who agree to its rules.
Can real-world data be used without moving it?
Yes. In a federated model, approved analysis runs where the data sits and only checked, aggregate results are returned.
Is de-identified real-world data free of privacy risk?
No. De-identification lowers risk but does not remove it, especially when data is linked. Access controls, secure settings and output checks are still needed.
How does governance affect real-world evidence quality?
Good governance documents where data came from and how it was transformed, which lets regulators and reviewers trace evidence back to its source and trust the result.
